Navigation Links
Nitric oxide: Key to cardiovascular and pulmonary function and drug effectiveness

A naturally occurring molecule in the body appears to control whether certain medications, such as beta adrenergic receptor agonists used in acute heart failure or in inhalers for asthma, lose their effectiveness over time.

Nitric oxide is a molecule produced by the body that controls many functions, including the contraction or dilation of blood vessels.

New experiments conducted by Duke University Medical Center and Howard Hughes Medical Institute researchers have shown that specialized forms of nitric oxide called SNOs may be the key to a problem that has stumped physicians for years -- why specific drugs for such diseases as heart failure or asthma lose their effectiveness over time.

Almost half of all drugs on the market today, as well as many hormone and neurotransmitters, target a specific family of cell surface receptors known as G-protein coupled receptors. The researchers believe that the presence or absence of nitric oxide or SNOs determines whether these receptors continue to function properly. This action is controlled by the ability of nitric oxide to inhibit a key regulatory system which ordinarily shuts the receptors off after they are stimulated

The researchers reported their latest findings on Friday, May 4, in the journal Cell.

"This work is significant in that it demonstrates how two of the most pervasive physiological systems -- G-protein coupled receptors and nitric oxide -- come together to influence one another," said Erin Whalen, Ph.D., who spent six years focusing on the link between the two biological systems. Whalen is a postdoctoral fellow in the laboratory of Robert Lefkowitz, M.D., a Howard Hughes Medical Institute investigator at Duke who first cloned these receptors in 1986. The link was cemented through a collaboration with Matt Foster, a post-doctoral fellow in the laboratory of Jonathan Stamler M.D.

G-protein coupled receptors reside on the cell surface where they interact
'"/>

Source:Duke University Medical Center


Page: 1 2 3

Related biology news :

1. Aspirin reduces cardiovascular risks in men and women -- but differently
2. Eating less salt could prevent cardiovascular disease
3. Study: Predatory dinosaurs had bird-like pulmonary system
4. Researchers develop gene therapy to reverse pulmonary arterial hypertension
5. Poor prenatal nutrition permanently damages function of insulin-producing cells in the pancreas
6. Automatic extraction of gene/protein biological functions from biomedical text
7. New research questions basic tenet of neuron function
8. Vascular structure and function improve with diet and exercise
9. Towards precise classification of cancers based on robust gene functional expression profiles
10. Researchers reveal secret of key protein in brain and heart function
11. By creating molecular bridge, scientists change function of a protein

Post Your Comments:
(Date:11/24/2009)... NEW YORK (November 24, 2009) -- The Wildlife C... revealing that the last remaining population of S...ue to the rising tide of poaching and habitat loss...form Russian officials of what needs to be done to...est cat. , The report was released ...
(Date:11/23/2009)...w research presents strong evidence that the "syne...door traffic-related pollution and indoor endotoxi... the other exposure alone. , Environmental hea...) College of Medicine have shown that children exp...les and indoor endotoxin during early life are six...
(Date:11/23/2009)...f. -- More than 160 participants gathered this wee...UTURES INITIATIVE conference. This year,s topic, "...ngineers, and medical researchers to explore the e...ing the emerging field of synthetic biology. , B...t Princeton University and this year,s conference ...
Breaking Biology News(10 mins):Report shows dramatic decline in Siberian tigers 2Exposure to both traffic, indoor pollutants puts some kids at higher risk for asthma later 2Synthetic biology offers new opportunities for interdisciplinary collaboration 2Leading Biotechnology Company Awards Phase III Cardiac Safety Study to iCardiac 14246 1Leading Biotechnology Company Awards Phase III Cardiac Safety Study to iCardiac 14246 2UMass Boston Researcher Partner Develop Non Invasive Technique for Lead Testing in Humans 58234 1UMass Boston Researcher Partner Develop Non Invasive Technique for Lead Testing in Humans 58234 2UMass Boston Researcher Partner Develop Non Invasive Technique for Lead Testing in Humans 58234 3Learn How to Treat Stress at HOLISTIC HEALTH NOW Conference Nov 5 7 in Cleveland Ohio 58232 1Learn How to Treat Stress at HOLISTIC HEALTH NOW Conference Nov 5 7 in Cleveland Ohio 58232 2Learn How to Treat Stress at HOLISTIC HEALTH NOW Conference Nov 5 7 in Cleveland Ohio 58232 3Learn How to Treat Stress at HOLISTIC HEALTH NOW Conference Nov 5 7 in Cleveland Ohio 58232 4
... The way the evangelical movement is defined has ...nto the political spectrum, according to a study b...ty of Texas-Austin. , "In this election year, the...e off enough evangelical votes to carry certain sw... the researchers. "That depends a great deal on wh...
... This release is available in German . , Pl...heir study now published in PLoS Biology, scientis...iology in Tbingen have shown that certain small se...rowth and aging processes in plants. These microRN...ription factors. These transcription factors in tu...
... This year,s Julius Springer Prize for Applied Ph...Heinz for their pioneering work on the electrical ...ls including carbon nanotubes − from basic s...anied by US$ 5,000, will be presented at the Juliu...d University in Cambridge, MA, on 27 September 200...
Other Biology News:New study looks to define evangelicals and how they affect polling 2Formula discovered for longer plant life 2Carbon nanostructures form the future of electronics and optoelectronics 2
(Date:11/27/2009)... , , DURHAM, N.C., Nov. 27 /PRNewsw...Park, will initiate water-soluble carbon nanotube-...dia. The water-soluble carbon nanotubes, which hav...onjugation with cancer drugs, was developed in par.... The conjugated carbon nanotubes serves as a drug...
(Date:11/25/2009)... , , DURHAM, N.C., Nov. 25 /PRNewsw...nveiled the first energy-efficient, single-treatme...d from carbon nanotubes to Andhra Pradesh, Ministe...d other leaders in Hyderabad, India today. Initial...y (IIT) Kanpur, confirmed that the majority of the...
(Date:11/25/2009)... , , MARKHAM, ON, Nov. 25 /PRNewswire/ - ...r Moldt, PhD to its Board of Directors. Dr. Moldt ...sentative on the Company,s Board. The number of Bo..., "We are very pleased to welcome Peter Moldt to t...xperience and guidance as Cytochroma continues to ...
(Date:11/24/2009)... , This release is available in German . ,...ication cards: RFID tags (Radio Frequency Identifi...eryday life. They make it possible to label object...o frequency. The appropriate scanner can read and ...els can be affixed to goods under production condi...
Breaking Biology Technology:North Carolina Based Cromoz Inc. Launches Carbon Nanotechnology for Target Drug Delivery System in Cancer Treatment in Hyderabad, India 2North Carolina-based Cnanoz Unveils NanoPure(TM) to Government Leaders in Hyderabad, India 2Cytochroma Announces Appointment of Peter Moldt to Board of Directors 2Intelligence inside metal components 2
...VANCOUVER, June 9 /PRNewswire/ - OncoGenex Technol...th Annual Biotechnology & Medical,Technology Confe...ce Hotel.,OncoGenex, President and Chief Executive...overview at the conference, including an overview ...om the American Society of,Clinical Oncology (ASCO...
...NEW YORK and LONDON, June 9 Paul Capital Healthca...acleod, Ph.D., will moderate,a panel on strategic ...nnovate Europe 08 conference. Designed to familiar...s a strategic approach to financing, the panel,"Fe... Strategy for Meeting,Biotechnology,s Capital Need...
...A Powerful New Tool for Early Identification of Hi...Help Prevent Disease Progression, SAN FRANCISCO, ... the 68th Scientific Sessions of the American Diab...ailability of its novel PreDx(TM) Diabetes,Risk Te...ers an accurate,assessment of an individual,s risk...
Other Biology Technology:OncoGenex to present at the Needham & Company 7th Annual Biotechnology & Medical Technology Conference 2OncoGenex to present at the Needham & Company 7th Annual Biotechnology & Medical Technology Conference 3Paul Capital Healthcare Leads Panel on Strategic Financing 2Tethys Bioscience Announces Expanded Availability of PreDx(TM) Diabetes Risk Test 2Tethys Bioscience Announces Expanded Availability of PreDx(TM) Diabetes Risk Test 3Tethys Bioscience Announces Expanded Availability of PreDx(TM) Diabetes Risk Test 4
RNase AWAY(r) from Sigma-Aldrich
TiterHigh Sf Insect Medium from Sigma-Aldrich
Corning Culture Flask, 25 cm2, Tc-Treated, Straight Neck, Vent Cap, Sterile from Sigma-Aldrich
Schneiders Insect Medium from Sigma-Aldrich
Biology Products: